Medcenter Nova Clinic Ltd.
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Medcenter Nova Clinic Ltd., research focuses on cardiovascular diseases such as atherosclerotic cardiovascular disease, atrial fibrillation, and high cholesterol, aiming to evaluate new treatments that reduce heart attacks, stroke risk, and improve heart rhythm.
- New therapies for cholesterol management
- Innovative approaches to reduce cardiovascular events
- Strategies for rhythm control in atrial fibrillation
The site in Varna, Bulgaria, leverages a multidisciplinary team to advance cardiovascular health.
Respiratory Tract Diseases
The clinic conducts studies on respiratory tract diseases, particularly moderate to severe chronic obstructive pulmonary disease (COPD), comparing inhaled formulations to improve lung function and quality of life.
- Comparison of inhaler propellants for COPD treatment
- Assessment of lung function outcomes
- Safety and efficacy of new bronchodilator combinations
Participants benefit from access to cutting‑edge respiratory research at the facility.
Immune System Diseases
Research at the site includes investigations into immune system diseases such as Graves’ disease and Sjögren’s disease, focusing on therapies that restore hormonal balance and reduce autoimmune activity.
- Evaluation of monoclonal antibodies for Sjögren’s disease
- Testing novel agents for thyroid autoimmunity
- Long‑term safety of immunomodulatory treatments
The program supports patients with autoimmune conditions through innovative clinical trials.
Nutritional and Metabolic Diseases
Clinical trials address nutritional and metabolic diseases, including type 2 diabetes, obesity, and hyperlipidemia, with the goal of testing weekly insulin regimens, weight‑loss agents, and cholesterol‑lowering drugs.
- Weekly insulin therapy for better glycaemic control
- Weight‑loss interventions for obesity management
- Agents targeting LDL‑C reduction
The facility’s metabolic research aims to improve long‑term health outcomes for patients.
Eye Diseases
The center also supports research in eye diseases, aiming to improve diagnostic tools and therapeutic options, though specific studies are in early development.
- Exploration of novel ocular drug delivery
- Assessment of visual function outcomes
- Safety profiling of emerging eye treatments
Ongoing work seeks to bring innovative eye care solutions to the region.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 18 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1AstraZeneca AB2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB4trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medcenter Nova Clinic Ltd.
lock Showing 1 of 18 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age with Functional Constipation (FC). | AbbVie Deutschland GmbH & Co. KG | Phase II | Not Recruiting | Dec 2023 | May 2025 |
IMP list
lock Showing 1 of 18 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 3 | Unknown | 2023-11-07 | 2023-11-07 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.